Tumor Test Marker YRA385 // YRA391

The Tumor Test Marker YRA385 // YRA391 offers an advanced and reliable method for detecting 18 different tumor markers, utilizing chemiluminescence immunoassay (CLIA) analyzers. This test kit is paramount for early cancer detection, highlighting elevated tumor marker levels in the blood, which are indicative of various malignant tumors. Its precision and efficiency make it a vital tool in medical diagnostics, catering to both high-volume and small-scale laboratories.

The kit covers a comprehensive range of markers, including but not limited to AFP, CEA, CA125, CA15-3, CA19-9, f-PSA, and t-PSA. With cutting-edge technology and stringent international certifications (CE, ISO13485, FSC), this product assures both clinicians and patients of its accuracy and reliability. Available in convenient package specifications of 50, 100, or 24 tests per box, it fits diverse laboratory workflow needs.

Market Price

While prices can vary based on region and supplier, the Tumor Test Marker YRA385 // YRA391 generally falls within a competitive range. On the market, these kits can be found priced between $500 to $1500, contingent on the box size and supplier terms. For those interested in tailored pricing, we offer the possibility to request a quote or create an automatic quote via our Kalstein Plus platform, ensuring you receive a price that best aligns with your needs.

Frequently Asked Questions

Q: How many tumor markers does this test kit detect?
A: The Tumor Test Marker YRA385 // YRA391 detects 18 different tumor markers.

Q: Is this test kit certified?
A: Yes, it holds certifications including CE, ISO13485, and FSC, ensuring its compliance with international standards.

Advantages and Disadvantages

The advantages of using the Tumor Test Marker YRA385 // YRA391 include its high sensitivity, efficient early detection capabilities, and broad detection range of markers. Additionally, its compatibility with CLIA analyzers ensures enhanced procedural workflow and accuracy. A potential disadvantage is the initial investment cost, particularly for smaller laboratories.

Field Use

This test kit is primarily utilized in clinical laboratories and hospitals for cancer screening and monitoring. Its role in early detection aids in planning preventative measures and treatment strategies efficiently. By delivering clear and accurate results, it supports oncologists and medical professionals in making informed decisions for patient care.

Recommendations

To maximize the benefit of the Tumor Test Marker YRA385 // YRA391, it is recommended to follow strict storage guidelines, maintaining the test kits at a temperature between 2-8°C. Regular calibration with the provided 2/6 points calibration model ensures continued accuracy and reliability of test results.

Features

• Designed for chemiluminescence immunoassay analyzers.
• Detects 18 different tumor markers.
• Supports early cancer detection.
• Available in various package sizes (50T/BOX, 100T/BOX, 24T/BOX).
• Certified with CE, ISO13485, and FSC.
• Uses Alkaline Phosphatase (AP) platform.

Technical Specifications